Consensus GeNeuro SA

Equities

GNRO

CH0308403085

Real-time Euronext Paris Other stock markets 05:28:03 2024-07-11 am EDT			5-day change	1st Jan Change
0.113 ^EUR	-9.96%		-37.22%	-89.63%

Jun. 28	GeNeuro: failure of phase 2 study in Covid long	CF
Jun. 28	GeNeuro Announces Results of the Gnc-501 Study in Post-Covid-19 Syndrome	CI

Evolution of the average Target Price on GeNeuro SA

Price target over the last 5 years

History of analyst recommendation changes

1eef556701e79d9d6ad32110fae.GnTjt48CL-WViT7wzwuf0oiKNZq1zHy1CvlrraSwvBc.XBqE0Oh3X9PWuXeWokqvlsDpWNnGpQzGJ84_6f3p0SFLQbze-GpHptTucw~6f2e3ae7cc85dbbf0fa2e9df326b662e

Analysts' Consensus

Sell

Buy

Mean consensus

UNDERPERFORM

Number of Analysts

Last Close Price

0.1255 EUR

Average target price

2.05 EUR

Spread / Average Target

+1,533.47%

High Price Target

4 EUR

Spread / Highest target

+3,087.25%

Low Price Target

0.1 EUR

Spread / Lowest Target

-20.32%

Consensus detail

Consensus revision (last 18 months)

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar